COMP <GO>
BLLN vs CDNA // ENTERPRISE SCALE & MARKET CAP
BillionToOne Inc. (NASDAQ) VS. CareDx Inc. (NASDAQ) • 15-METRIC TALLY: BLLN 7
— CDNA 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BLLN
LAST: $110.41 (-2.57%) • MKT CAP: $5.35B
market-cap
$5.35B
LAST: $85.88 (-1.75%) • MKT CAP: $4.59B
market-cap
$4.59B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLLN VS. CDNA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLLN | CDNA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.90% | -8.20% | +11.10 | BLLN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.29% | 0.67% | -0.38 | CDNA | /fcf-yield <GO> |
| Operating Margin | 5.30% | -8.10% | +13.40 | BLLN | /operating-margins <GO> |
| Net Profit Margin | 2.40% | -5.60% | +8.00 | BLLN | /net-margins <GO> |
| Revenue Growth (YoY) | 100.00% | 13.80% | +86.20 | BLLN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 22.24 | 19.22 | +3.02 | BLLN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | BLLN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.4 | 67.4 | -9.00 | CDNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.06 | -0.04 | CDNA | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.35B | $4.59B | $754.5M | BLLN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLLN REV | CDNA REV | BLLN GROSS % | CDNA GROSS % | BLLN FCF | CDNA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $305.1M | $379.8M | 68.3% | — | $15.7M | $24.9M |
| FY 2024 | $152.6M | $333.8M | 53.0% | — | -$46.8M | $23.0M |
| FY 2023 | $71.7M | $280.3M | — | — | -$56.9M | -$31.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLLN // BETA 1.02
CDNA // BETA 1.06